Table 2.
Biopsies | Location | TIMP3 | APC | CDKN2A | MLH1 | CDKN2B | TP73 | FANCD2 | DAPK1 | ESR | GSTP1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Case 1—IP | 1—reference | Nasal | M | M | M | M | M | M | ||||
2–10 months | Ethmoid and nasal maxillary-block 3 | M | M | M | ||||||||
2–10 months | Ethmoid and nasal maxillary-block 4 | M | ||||||||||
Case 2—IP | 1—reference | Nasal cavity | M | M | M | M | ||||||
2–6 months | Ethmoid sinus | M | ||||||||||
Case 3—IP | 1—reference | Ethmoid sinus | M | |||||||||
Case 4—IP/EP | 1—reference | Nasal mucosa | M | M | ||||||||
Case 5—IP/EP | 1—reference | Nasal vestibule | M | |||||||||
Case 6—EP | 1—reference | Frontal sinus | M | M | ||||||||
Case 7—EP | 1—reference | Nasal cavity | M | |||||||||
Total | 1/7 | 1/7 | 2/7 | 1/7 | 6/7 | 2/7 | 1/7 | 1/7 | 2/7 | 1/7 |
EP, exophytic papilloma; IP/EP, inverted and exophytic papilloma; IP, inverted papilloma; M, methylated.